1. Gtpl7055
2. Q420394
3. [({[(2s,3r,4s,5r,6r)-4,5-bis({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-6-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]-2-{[(2r,3s,4s,5r)-3,4,5-tris({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-2-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]oxolan-2-yl]oxy}oxan-3-yl]oxy}sulfonyl)oxy]alumanediol
Molecular Weight | 1464.8 g/mol |
---|---|
Molecular Formula | C11H44Al8O51S8 |
Hydrogen Bond Donor Count | 16 |
Hydrogen Bond Acceptor Count | 51 |
Rotatable Bond Count | 36 |
Exact Mass | 1463.713824 g/mol |
Monoisotopic Mass | 1463.713824 g/mol |
Topological Polar Surface Area | 532 Ų |
Heavy Atom Count | 78 |
Formal Charge | 0 |
Complexity | 2400 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 17 |
1 of 2 | |
---|---|
Drug Name | Carafate |
PubMed Health | Sucralfate (By mouth) |
Drug Classes | Antiulcer, Protectant |
Drug Label | CARAFATE Suspension contains sucralfate and sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.CARAFATE Suspension for oral administration contains 1 g of sucralfate per 10 mL.CARAFATE Sus... |
Active Ingredient | Sucralfate |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 1gm/10ml; 1gm |
Market Status | Prescription |
Company | Forest Labs |
2 of 2 | |
---|---|
Drug Name | Carafate |
PubMed Health | Sucralfate (By mouth) |
Drug Classes | Antiulcer, Protectant |
Drug Label | CARAFATE Suspension contains sucralfate and sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.CARAFATE Suspension for oral administration contains 1 g of sucralfate per 10 mL.CARAFATE Sus... |
Active Ingredient | Sucralfate |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 1gm/10ml; 1gm |
Market Status | Prescription |
Company | Forest Labs |
LOOKING FOR A SUPPLIER?